Share of people with HIV who receive antiretroviral therapy in Algeria
Algeria: Share of people with HIV who receive antiretroviral therapy was 68.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Algeria, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Algeria stood at 68.0%.
The figure is down 4.2% on the previous year and up 58.1% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Algeria peaked at 74.0% in 2021 and was at its lowest, 6.0%, in 2000.
Algeria ranks 82nd of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Algeria, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 6.0% | — |
| 2001 | 7.0% | +16.7% |
| 2002 | 8.0% | +14.3% |
| 2003 | 8.0% | +0.0% |
| 2004 | 9.0% | +12.5% |
| 2005 | 10.0% | +11.1% |
| 2006 | 13.0% | +30.0% |
| 2007 | 13.0% | +0.0% |
| 2008 | 13.0% | +0.0% |
| 2009 | 16.0% | +23.1% |
| 2010 | 21.0% | +31.2% |
| 2011 | 23.0% | +9.5% |
| 2012 | 28.0% | +21.7% |
| 2013 | 35.0% | +25.0% |
| 2014 | 43.0% | +22.9% |
| 2015 | 51.0% | +18.6% |
| 2016 | 59.0% | +15.7% |
| 2017 | 64.0% | +8.5% |
| 2018 | 69.0% | +7.8% |
| 2019 | 72.0% | +4.3% |
| 2020 | 72.0% | +0.0% |
| 2021 | 74.0% | +2.8% |
| 2022 | 69.0% | -6.8% |
| 2023 | 71.0% | +2.9% |
| 2024 | 68.0% | -4.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.3% | 6.0% | 16.0% | 10 |
| 2010s | 46.5% | 21.0% | 72.0% | 10 |
| 2020s | 70.8% | 68.0% | 74.0% | 5 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Population ages 65-69, male, annual growth rate 3.9 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0135 units per person (2025)
- Population ages 70-74, female, annual growth rate 5.3 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.01 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Algeria?
- Share of people with hiv who receive antiretroviral therapy in Algeria was 68.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Algeria?
- The highest recorded value was 74.0% in 2021.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Algeria?
- The lowest recorded value was 6.0% in 2000.
- How does Algeria rank for share of people with hiv who receive antiretroviral therapy?
- Algeria ranks 82nd out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Algeria?
- Over the last ten years it is up 58.1%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.